Indegene Quarterly Results for Trading Insights

INDGN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹102 Cr
QSept 2025
Quarterly Results

Indegene Quarterly Results Key Highlights

  • Revenue of ₹824 Cr in Sept 2025 (+5.5% vs Mar 2025, +16.4% vs Sept 2024)
  • Net Profit of ₹102 Cr in Sept 2025 (-13.6% vs Mar 2025, +10.9% vs Sept 2024)
  • EBITDA of ₹160 Cr in Sept 2025 (-7.5% vs Mar 2025)
  • Operating Margin of 17.0% in Sept 2025 (-3.0pp vs Mar 2025)
  • Earnings Per Share of ₹4.26 in Sept 2025 (-13.2% vs Mar 2025)

Indegene Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 824 781 783 708 699 5.5% 16.4%
Net Profit (₹ Cr) 102 118 116 92 95 - -
EBITDA (₹ Cr) 160 173 177 148 164 - -
EPS (₹) 4.26 4.91 4.86 3.84 4.27 - -
Operating Margin (%) 17.0% 20.0% 20.0% 18.0% 21.0% - -

Indegene Share Price Trend Around Quarterly Results

Visualize Indegene's 1-year price movement across quarterly results — ideal for logging trades in Indegene share price chart using Tickjournal. All values in ₹.

Related Pages for Indegene

Additional stock information and data for INDGN

INDGN market cap trends
Indegene share price today live chart
INDGN dividend payout details
Indegene ownership structure
INDGN intrinsic value calculation
Indegene share price performance
INDGN income statement
INDGN price range

Profitability Ratios

Profit Margin 12.4%
EBITDA Margin 19.4%
Operating Margin 17.0%
ROE (Annual) 15.6%

Balance Sheet Highlights

Total Assets ₹3,326 Cr
Total Equity ₹2,616 Cr
Current Assets ₹2,530 Cr
Current Liabilities ₹146 Cr

Cash Flow Analysis

Operating Cash Flow ₹442 Cr
Investing Cash Flow ₹-677 Cr
Financing Cash Flow ₹288 Cr
Net Cash Flow ₹52 Cr

Current Market Data

Current Price ₹522.60
Exchange NSE
Last Updated Jan 06, 2026

Revenue Trend (₹ Cr)

Sept 2024 708
Jun 2025 783
Mar 2025 781
Sept 2025 824

Net Profit Trend (₹ Cr)

Sept 2024 92
Jun 2025 116
Mar 2025 118
Sept 2025 102

Operating Margin Trend (%)

Sept 2024 18.0%
Jun 2025 20.0%
Mar 2025 20.0%
Sept 2025 17.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Indegene quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹422,330.94 Cr 1760.2 14,875 3,125 +10.8% - 21.0% 135.4
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 3936.8 3,219 591 +11.3% - 18.4% 224.4
Cipla
Sept 2025 		₹121,238.47 Cr 1530.8 7,716 1,353 +12.0% - 17.5% 91.5
Dr Reddys Laborator…
Sept 2025 		₹104,829.57 Cr 1256.2 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores